171
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

HSP90-Dependent Upregulation of EZH2 Promotes Hypoxia/Reoxygenation-Induced Pyroptosis by Inhibiting miR-22 in Endothelial Cells

& ORCID Icon
Pages 2615-2630 | Received 04 Jan 2023, Accepted 15 Jun 2023, Published online: 19 Jun 2023

References

  • Akhmerov A, Parimon T. Extracellular vesicles, inflammation, and cardiovascular disease. Cells. 2022;11(14):2229. doi:10.3390/cells11142229
  • Lu Y, Luo Y, Zhu R, Huang X, Bai S. Advanced bioactive hydrogels for the treatment of myocardial infarction. J Mater Chem B. 2022;10(41):8375–8385. doi:10.1039/d2tb01591a
  • Liao Z, Chen Y, Duan C, et al. Cardiac telocytes inhibit cardiac microvascular endothelial cell apoptosis through exosomal miRNA-21-5p-targeted cdip1 silencing to improve angiogenesis following myocardial infarction. Theranostics. 2021;11(1):268–291. doi:10.7150/thno.47021
  • Wu X, Zhang H, Qi W, et al. Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis. Cell Death Dis. 2018;9(2):171. doi:10.1038/s41419-017-0257-3
  • Penna C, Femmino S, Caldera F, et al. Cyclic nigerosyl-nigerose as oxygen nanocarrier to protect cellular models from hypoxia/reoxygenation injury: implications from an in vitro model. Int J Mol Sci. 2021;22(8):4208. doi:10.3390/ijms22084208
  • Zhou R, Huang W, Fan X, et al. miR-499 released during myocardial infarction causes endothelial injury by targeting alpha7-nAchR. J Cell Mol Med. 2019;23(9):6085–6097. doi:10.1111/jcmm.14474
  • Zheng Z, Li G. Mechanisms and therapeutic regulation of pyroptosis in inflammatory diseases and cancer. Int J Mol Sci. 2020;21(4):1456. doi:10.3390/ijms21041456
  • Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128. doi:10.1038/s41392-021-00507-5
  • Qiu Z, He Y, Ming H, Lei S, Leng Y, Xia ZY. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019;2019:8151836. doi:10.1155/2019/8151836
  • Yao T, Song Y, Li S, Gu J, Yan X. Inhibition of lncRNA NEAT1 protects endothelial cells against hypoxia/reoxygenation induced NLRP3 inflammasome activation by targeting the miR204/BRCC3 axis. Mol Med Rep. 2022;25(1). doi:10.3892/mmr.2021.12548
  • Sun W, Lu H, Dong S, et al. Beclin1 controls caspase-4 inflammsome activation and pyroptosis in mouse myocardial reperfusion-induced microvascular injury. Cell Commun Signal. 2021;19(1):107. doi:10.1186/s12964-021-00786-z
  • Zhang B, Liu G, Huang B, et al. KDM3A attenuates myocardial ischemic and reperfusion injury by ameliorating cardiac microvascular endothelial cell pyroptosis. Oxid Med Cell Longev. 2022;2022:4622520. doi:10.1155/2022/4622520
  • Liu Y, Li P, Qiao C, et al. Chitosan hydrogel enhances the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction by alleviating vascular endothelial cell pyroptosis. J Cardiovasc Pharmacol. 2020;75(1):75–83. doi:10.1097/FJC.0000000000000760
  • Pelletier D, Rivera B, Fabian MR, Foulkes WD. miRNA biogenesis and inherited disorders: clinico-molecular insights. Trends Genet. 2023;39(5):401–414. doi:10.1016/j.tig.2023.01.009
  • Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics: from cells to clinic. Trends Genet. 2022;38(6):613–626. doi:10.1016/j.tig.2022.02.006
  • Wang F, Gu L, Wang Y, et al. MicroRNA-122a aggravates intestinal ischemia/reperfusion injury by promoting pyroptosis via targeting EGFR-NLRP3 signaling pathway. Life Sci. 2022;307:120863. doi:10.1016/j.lfs.2022.120863
  • Miao Z, Miao Z, Teng X, Xu S. Chlorpyrifos triggers epithelioma papulosum cyprini cell pyroptosis via miR-124-3p/CAPN1 axis. J Hazard Mater. 2022;424(Pt A):127318. doi:10.1016/j.jhazmat.2021.127318
  • Heo MJ, Kim TH, You JS, Blaya D, Sancho-Bru P, Kim SG. Alcohol dysregulates miR-148a in hepatocytes through FoxO1, facilitating pyroptosis via TXNIP overexpression. Gut. 2019;68(4):708–720. doi:10.1136/gutjnl-2017-315123
  • Chi K, Geng X, Liu C, et al. LncRNA-HOTAIR promotes endothelial cell pyroptosis by regulating the miR-22/NLRP3 axis in hyperuricaemia. J Cell Mol Med. 2021;25(17):8504–8521. doi:10.1111/jcmm.16812
  • Zhang HS, Ouyang B, Ji XY, Liu MF. Gastrodin alleviates cerebral ischaemia/reperfusion injury by inhibiting pyroptosis by regulating the lncRNA NEAT1/miR-22-3p axis. Neurochem Res. 2021;46(7):1747–1758. doi:10.1007/s11064-021-03285-2
  • Song Z, Zhang Y, Gong B, Xu H, Hao Z, Liang C. Long noncoding RNA LINC00339 promotes renal tubular epithelial pyroptosis by regulating the miR-22-3p/NLRP3 axis in calcium oxalate-induced kidney stone. J Cell Biochem. 2019;120(6):10452–10462. doi:10.1002/jcb.28330
  • Song Y, Yang L, Guo R, Lu N, Shi Y, Wang X. Long noncoding RNA MALAT1 promotes high glucose-induced human endothelial cells pyroptosis by affecting NLRP3 expression through competitively binding miR-22. Biochem Biophys Res Commun. 2019;509(2):359–366. doi:10.1016/j.bbrc.2018.12.139
  • Wang J, Wang GG. No easy way out for EZH2: its pleiotropic, noncanonical effects on gene regulation and cellular function. Int J Mol Sci. 2020;21(24):9501. doi:10.3390/ijms21249501
  • Duan R, Du W, Guo W. EZH2: a novel target for cancer treatment. J Hematol Oncol. 2020;13(1):104. doi:10.1186/s13045-020-00937-8
  • Nutt SL, Keenan C, Chopin M, Allan RS. EZH2 function in immune cell development. Biol Chem. 2020;401(8):933–943. doi:10.1515/hsz-2019-0436
  • Ito T, Teo YV, Evans SA, Neretti N, Sedivy JM. Regulation of cellular senescence by polycomb chromatin modifiers through distinct DNA damage- and histone methylation-dependent pathways. Cell Rep. 2018;22(13):3480–3492. doi:10.1016/j.celrep.2018.03.002
  • Yao Y, Hu H, Yang Y, et al. Downregulation of Enhancer of Zeste Homolog 2 (EZH2) is essential for the induction of autophagy and apoptosis in colorectal cancer cells. Genes. 2016;7(10):83. doi:10.3390/genes7100083
  • Batool A, Jin C, Liu YX. Role of EZH2 in cell lineage determination and relative signaling pathways. Front Biosci. 2019;24(5):947–960. doi:10.2741/4760
  • Liu H, Chen Z, Weng X, et al. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model. FASEB J. 2020;34(1):835–852. doi:10.1096/fj.201901816R
  • Cai B, Li M, Zheng Y, et al. EZH2-mediated inhibition of microRNA-22 promotes differentiation of hair follicle stem cells by elevating STK40 expression. Aging. 2020;12(13):12726–12739. doi:10.18632/aging.103165
  • Chen S, Wang G, Tao K, et al. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis. Cancer Sci. 2020;111(5):1582–1595. doi:10.1111/cas.14372
  • Wang C, Liu G, Yang H, et al. MALAT1-mediated recruitment of the histone methyltransferase EZH2 to the microRNA-22 promoter leads to cardiomyocyte apoptosis in diabetic cardiomyopathy. Sci Total Environ. 2021;766:142191. doi:10.1016/j.scitotenv.2020.142191
  • Gu X, Xu Y, Xue WZ, et al. Interplay of miR-137 and EZH2 contributes to the genome-wide redistribution of H3K27me3 underlying the Pb-induced memory impairment. Cell Death Dis. 2019;10(9):671. doi:10.1038/s41419-019-1912-7
  • Kwon H, Song K, Han C, et al. Epigenetic silencing of miRNA-34a in human cholangiocarcinoma via EZH2 and DNA methylation: impact on regulation of notch pathway. Am J Pathol. 2017;187(10):2288–2299. doi:10.1016/j.ajpath.2017.06.014
  • Lin JM, Hsu CH, Chen JC, Kao SH, Lin YC. BCL-6 promotes the methylation of miR-34a by recruiting EZH2 and upregulating CTRP9 to protect ischemic myocardial injury. Biofactors. 2021;47(3):386–402. doi:10.1002/biof.1704
  • Li Y, Gan Y, Liu J, et al. Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer. Signal Transduct Target Ther. 2022;7(1):87. doi:10.1038/s41392-022-00902-6
  • Huang S, Wang Z, Zhou J, et al. EZH2 inhibitor GSK126 suppresses antitumor immunity by driving production of myeloid-derived suppressor cells. Cancer Res. 2019;79(8):2009–2020. doi:10.1158/0008-5472.CAN-18-2395
  • Hu Z, Lv X, Chen L, et al. Protective effects of microRNA-22-3p against retinal pigment epithelial inflammatory damage by targeting NLRP3 inflammasome. J Cell Physiol. 2019;234(10):18849–18857. doi:10.1002/jcp.28523
  • Yang K, Li W, Duan W, et al. Resveratrol attenuates pulmonary embolism associated cardiac injury by suppressing activation of the inflammasome via the MALAT1miR223p signaling pathway. Int J Mol Med. 2019;44(6):2311–2320. doi:10.3892/ijmm.2019.4358
  • Lee YC, Chang WW, Chen YY, et al. Hsp90alpha mediates BMI1 expression in breast cancer stem/progenitor cells through facilitating nuclear translocation of c-Myc and EZH2. Int J Mol Sci. 2017;18(9):1986. doi:10.3390/ijms18091986
  • Huang Q, He S, Tian Y, et al. Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice. Blood. 2017;129(20):2737–2748. doi:10.1182/blood-2016-08-735886
  • Zhou Z, Li X, Qian Y, Liu C, Huang X, Fu M. Heat shock protein 90 inhibitors suppress pyroptosis in THP-1 cells. Biochem J. 2020;477(20):3923–3934. doi:10.1042/BCJ20200351
  • Bulek K, Zhao J, Liao Y, et al. Epithelial-derived gasdermin D mediates nonlytic IL-1beta release during experimental colitis. J Clin Invest. 2020;130(8):4218–4234. doi:10.1172/JCI138103
  • Zhang T, Wu DM, Luo PW, et al. CircNEIL3 mediates pyroptosis to influence lung adenocarcinoma radiotherapy by upregulating PIF1 through miR-1184 inhibition. Cell Death Dis. 2022;13(2):167. doi:10.1038/s41419-022-04561-x
  • Ye Y, Feng Z, Tian S, et al. HBO alleviates neural stem cell pyroptosis via lncRNA-H19/miR-423-5p/NLRP3 axis and improves neurogenesis after oxygen glucose deprivation. Oxid Med Cell Longev. 2022;2022:9030771. doi:10.1155/2022/9030771
  • Chu C, Wang B, Zhang Z, et al. miR-513c-5p suppression aggravates pyroptosis of endothelial cell in deep venous thrombosis by promoting caspase-1. Front Cell Dev Biol. 2022;10:838785. doi:10.3389/fcell.2022.838785
  • Zheng X, Zhao X, Han Z, Chen K. Enhancer of zeste homolog 2 participates in the process of atherosclerosis by modulating microRNA-139-5p methylation and signal transducer and activator of transcription 1 expression. IUBMB Life. 2021;73(1):238–251. doi:10.1002/iub.2423
  • Meng K, Jiao J, Zhu RR, et al. The long noncoding RNA hotair regulates oxidative stress and cardiac myocyte apoptosis during ischemia-reperfusion injury. Oxid Med Cell Longev. 2020;2020:1645249. doi:10.1155/2020/1645249
  • Xu Z, Xi K. LncRNA RGMB-AS1 promotes laryngeal squamous cell carcinoma cells progression via sponging miR-22/NLRP3 axis. Biomed Pharmacother. 2019;118:109222. doi:10.1016/j.biopha.2019.109222
  • Gao Y, Li X, Zeng C, et al. CD63(+) cancer-associated fibroblasts confer tamoxifen resistance to breast cancer cells through exosomal miR-22. Adv Sci. 2020;7(21):2002518. doi:10.1002/advs.202002518
  • Wang X, Wang Y, Kong M, Yang J. MiR-22-3p suppresses sepsis-induced acute kidney injury by targeting PTEN. Biosci Rep. 2020;40(6). doi:10.1042/BSR20200527
  • Li C, Zhang L, Bu X, Chu G, Zhao X, Liu Y. LncRNA NORAD promotes the progression of myocardial infarction by targeting the miR-22-3p/PTEN axis. Acta Biochim Biophys Sin. 2022;54(4):463–473. doi:10.3724/abbs.2022037
  • Zha X, Xi X, Fan X, Ma M, Zhang Y, Yang Y. Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/PTEN/Akt signaling cascade through DGCR8. Aging. 2020;12(9):8137–8150. doi:10.18632/aging.103130
  • Ning JZ, He KX, Cheng F, et al. Long non-coding RNA MEG3 promotes pyroptosis in testicular ischemia-reperfusion injury by targeting MiR-29a to modulate PTEN expression. Front Cell Dev Biol. 2021;9:671613. doi:10.3389/fcell.2021.671613
  • Wang JJ, Chen ZL, Wang DD, Wu KF, Huang WB, Zhang LQ. linc00174 deteriorates the pathogenesis of diabetic retinopathy via miR-26a-5p/PTEN/Akt signalling cascade-mediated pyroptosis. Biochem Biophys Res Commun. 2022;630:92–100. doi:10.1016/j.bbrc.2022.09.016
  • Li Y, Li H, Zhou L. EZH2-mediated H3K27me3 inhibits ACE2 expression. Biochem Biophys Res Commun. 2020;526(4):947–952. doi:10.1016/j.bbrc.2020.04.010
  • Liu X, Li C, Zhang R, et al. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells. Cell Signal. 2018;51:243–256. doi:10.1016/j.cellsig.2018.08.011
  • Yun J, Ji YS, Jang GH, et al. TET2 mutation and high miR-22 expression as biomarkers to predict clinical outcome in myelodysplastic syndrome patients treated with hypomethylating therapy. Curr Issues Mol Biol. 2021;43(2):917–931. doi:10.3390/cimb43020065
  • Vire E, Brenner C, Deplus R, et al. The polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439(7078):871–874. doi:10.1038/nature04431
  • Sima S, Richter K. Regulation of the Hsp90 system. Biochim Biophys Acta Mol Cell Res. 2018;1865(6):889–897. doi:10.1016/j.bbamcr.2018.03.008